胰島素樣生長(zhǎng)因子結(jié)合蛋白7(IGFBP7)多克隆抗體
Polyclonal Antibody to Insulin Like Growth Factor Binding Protein 7 (IGFBP7)
FSTL2; IGFBP-7v; MAC25; PSF; TAF; IGFBP-rP1; MAC25 protein; Prostacyclin-stimulating factor; PGI2-stimulating factor; Tumor-derived adhesion factor
- 編號(hào)PAB673Mu02
- 物種Mus musculus (Mouse，小鼠) 相同的名稱，不同的物種。
- 來(lái)源多抗制備
- 宿主兔
- 效價(jià)-
- Ig類型 IgG
- 純化方式抗原特異性親和純化
- 標(biāo)記物無(wú)標(biāo)記物
- 免疫原 -
- 緩沖液成份磷酸鹽緩沖液（pH7.4,含有0.02% NaN3和50%甘油）
- 性狀液體
- 濃度500μg/mL
- 且適物種-
- 應(yīng)用WB; IHC; ICC; IP.
如果抗體需用于流式細(xì)胞術(shù)，請(qǐng)參見(jiàn)流式抗體。 - 下載 英文說(shuō)明書(shū) 中文說(shuō)明書(shū)
- 規(guī)格 20μl100μl 200μl 1ml 10ml
- 價(jià)格 ¥ 616 ¥ 1436 ¥ 2052 ¥ 5130 ¥ 20520
- 欲了解實(shí)際交易價(jià)格和更多情況，請(qǐng)與當(dāng)?shù)亟?jīng)銷商聯(lián)系!
-
產(chǎn)品包裝(模擬)
-
產(chǎn)品包裝(模擬)
-
通過(guò)ISO 9001、ISO 13485質(zhì)量體系認(rèn)證
特異性
該抗體是針對(duì)IGFBP7的兔多克隆抗體。在免疫組織化學(xué)染色和免疫印跡實(shí)驗(yàn)中能識(shí)別IGFBP7。
用法
免疫印跡：0.2-2μg/mL;1:250-2500
免疫組織化學(xué)：5-20μg/mL;1:25-100
免疫細(xì)胞化學(xué)：5-20μg/mL;1:25-100
最佳稀釋倍數(shù)最終由用戶決定。
儲(chǔ)存
經(jīng)常使用則4°C保存。-20°C保存不超過(guò)兩年。避免反復(fù)凍融。
穩(wěn)定性
熱穩(wěn)定性以損失率顯示。損失率是由加速降解試驗(yàn)決定，具體方法如下：在37°C孵育48小時(shí)，沒(méi)有顯著的降解或者沉淀產(chǎn)生。保質(zhì)期內(nèi)，在適當(dāng)?shù)臈l件下存儲(chǔ)，損失率低于5%。
贈(zèng)品
增值服務(wù)
抗體標(biāo)記定制服務(wù)
Protein-A/G純化柱
細(xì)胞和組織染色液
抗體陽(yáng)性對(duì)照品
組織/切片定制服務(wù)
磷酸化抗體定制服務(wù)
免疫印跡(WB)實(shí)驗(yàn)服務(wù)
免疫組織化學(xué)(IHC)實(shí)驗(yàn)服務(wù)
免疫細(xì)胞化學(xué)(ICC)實(shí)驗(yàn)服務(wù)
流式細(xì)胞術(shù)(FCM)實(shí)驗(yàn)服務(wù)
免疫沉淀(IP)實(shí)驗(yàn)服務(wù)
免疫熒光(IF)實(shí)驗(yàn)服務(wù)
緩沖液
DAB顯色試劑盒
SABC試劑盒
長(zhǎng)臂生物素標(biāo)記試劑盒
實(shí)時(shí)熒光定量PCR實(shí)驗(yàn)服務(wù)
相關(guān)產(chǎn)品
| 編號(hào) | 適用物種：Mus musculus (Mouse，小鼠) | 應(yīng)用(僅供研究使用，不用于臨床診斷！) |
| RPB673Mu02 | 胰島素樣生長(zhǎng)因子結(jié)合蛋白7(IGFBP7)重組蛋白 | Positive Control; Immunogen; SDS-PAGE; WB. |
| RPB673Mu01 | 胰島素樣生長(zhǎng)因子結(jié)合蛋白7(IGFBP7)重組蛋白 | Positive Control; Immunogen; SDS-PAGE; WB. |
| PAB673Mu02 | 胰島素樣生長(zhǎng)因子結(jié)合蛋白7(IGFBP7)多克隆抗體 | WB; IHC; ICC; IP. |
| PAB673Mu01 | 胰島素樣生長(zhǎng)因子結(jié)合蛋白7(IGFBP7)多克隆抗體 | WB; IHC; ICC; IP. |
| SEB673Mu | 胰島素樣生長(zhǎng)因子結(jié)合蛋白7(IGFBP7)檢測(cè)試劑盒(酶聯(lián)免疫吸附試驗(yàn)法) | Enzyme-linked immunosorbent assay for Antigen Detection. |
| LMB673Mu | 胰島素樣生長(zhǎng)因子結(jié)合蛋白7(IGFBP7)等多因子檢測(cè)試劑盒(流式熒光發(fā)光法) | FLIA Kit for Antigen Detection. |
參考文獻(xiàn)
| 雜志 | 參考文獻(xiàn) |
| PLoS One | Role of IGFBP7 in Diabetic Nephropathy: TGF-β1 Induces IGFBP7 via Smad2/4 in Human Renal Proximal Tubular Epithelial Cells [Pubmed:26974954] |
| PLOS?ONE | Role?of?IGFBP7?in?Diabetic?Nephropathy:?TGF-β1 Induces?IGFBP7?via Smad2/4 in Human Renal Proximal Tubular Epithelial Cells. [pubmed:26974954] |
| Journal of?Alzheimers?Disease | Urine-Based Biomarkers for Alzheimer's Disease Identified Through Coupling Computational and Experimental Methods [Pubmed:30040720] |
| Cancers (Basel). | IGFBP7 Drives Resistance to Epidermal Growth Factor Receptor Tyrosine Kinase Inhibition in Lung Cancer [Pubmed: 30609749] |
| Advances in?Medical?Sciences | Insulin-like growth factor-binding protein 7 (IGFBP 7) as a new biomarker in coronary heart disease [Pubmed: 30769262] |
| PLoS One | Altered insulin-like growth factor-2 signaling is associated with psychopathology and cognitive deficits in patients with schizophrenia [Pubmed: 32191705] |
| Scientific reports | Discovery of novel biomarkers for atherosclerotic aortic aneurysm through proteomics-based assessment of disease progression [Pubmed: 32286426] |
| Genet Med | SNORD116 and growth hormone therapy impact IGFBP7 in Prader¨CWilli syndrome [34040195] |
| Sci Rep | Biomarkers of persistent renal vulnerability after acute kidney injury recovery [34707157] |
| Biomolecules | IGFBP7 Concentration May Reflect Subclinical Myocardial Damage and Kidney Function in Patients with Stable Ischemic Heart Disease [Pubmed:35204773] |
| Biomolecules | Insulin-Like Growth Factor-Binding Protein 7 (IGFBP-7)—New Diagnostic and Prognostic Marker in Symptomatic Peripheral Arterial Disease?—Pilot Study [Pubmed:35625639] |
